Inovio Pharmaceuticals Inc (INO)

[Opus X]

Looks like Advaccine has been approved to be traded in China.

https://www.xinsanbanbao.com/20230103/news/n70228.html

Go to link and translate or see below.

Advaccine's #1 product is Inovio's INO-4800.

To me this is the way that it has been setup to follow with announcement Chinese approval of some distribution in China soon.

Also further clarification on above link:

55 Beijing Aideweixin Biotechnology Co., Ltd. Beijing Pharmaceutical Manufacturing CITIC Securities Co., Ltd. Lai Yiran Beijing Zhonglun Law Firm Li Pan, Song Yuanyuan Shine Wing Zhonghe Certified Public Accountants (Special General Partnership) Liu Yuehua, Luo Laiqian No 2022 -11-24 2022-12-01 2022-12-22

What is Beijing Pharma? https://www.bloomberg.com/profile/company/BMEDGZ:CH Beijing Pharmaceutical Group Co., Ltd. manufactures medicines. The Company develops, produces, and distributes chemical medicine preparations, antibiotics, biochemical drugs, and other related medicines. Beijing Pharmaceutical Group markets its products throughout China.

What is CITIC? https://en.wikipedia.org/wiki/CITIC_Group CITIC Group Corporation Ltd., formerly the China International Trust Investment Corporation (CITIC), is a state-owned investment company of the People's Republic of China, established by Rong Yiren in 1979 with the approval of Deng Xiaoping.[2] Its headquarters are in Chaoyang District, Beijing.[3] As of 2019, it is China's biggest state-run conglomerate[4] with one of the largest pools of foreign assets in the world.[5]

See https://www.citic.com/uploadfile/2022/0421/20220421263121.pdf : In our healthcare business, [CITIC's subsidiary] DCH Auriga offers tailored supply chain solutions to leading healthcare companies, distributing pharmaceuticals, vaccines, over-the-counter medicine, medical devices, personal care, nutrition and hospital consumables. Leveraging specialised infrastructure and capabilities including emergency delivery, robotic picking, real-time RFID tracking and advanced temperature management, DCH Auriga continued to grow its business across the region. This year, it opened a new sales office in Vietnam and now has operations in ten Asian economies. In 2021, DCH Auriga was appointed as the exclusive logistics provider for the Fosun-BioNTech COVID-19 vaccine in Hong Kong and Macau. It also distributed the Sinovac vaccine in Hong Kong and supported the distribution of treatments for COVID-19 patients in Singapore. It also launched an online pharmacy, Aurigamart.com, offering home delivery and direct access to an extensive over-the-counter product portfolio.